Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MRC initiates trial to improve survival of patients with resectable NSCLC

July 8, 1997

Troponin I inhibits breast cancer growth in preclinical trial

July 8, 1997

Navelbine introduced in the U.K.

July 8, 1997

Update on DepoTech's DepoCyt

July 8, 1997

Sanwa Kagaku characterizes analogues of dynemicin A

July 8, 1997

Double identity of Bcl-2 protein described

July 7, 1997

Inhibitors of tyrosine kinase disclosed by Pharmacia & Upjohn

July 7, 1997

Sugen files IND for angiogenesis inhibitor

July 3, 1997

ACT licenses rights to patents related to dendritic cell therapy

July 3, 1997

Kyowa Hakko discovers antitumor compounds in Streptomyces culture

July 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.